Tenet Healthcare (THC) — insider trading
Health Care · NYSE
Tenet Healthcare (THC) has 67 reported SEC Form 4 insider transactions in our data, including 25 open-market sales among the most recent 67 (latest 2026-09-14).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-09-14 | KERREY J ROBERT | Director | Open-market sale | 2,502 | $264.62 | $662.1K | Form 4 |
| 2026-09-14 | KERREY J ROBERT | Director | Open-market sale | 4,025 | $264.10 | $1.06M | Form 4 |
| 2026-09-14 | KERREY J ROBERT | Director | Open-market sale | 5,483 | $263.04 | $1.44M | Form 4 |
| 2026-09-10 | MARK RICHARD J | Director | Open-market sale | 10,000 | $263.42 | $2.63M | Form 4 |
| 2026-09-02 | West Nadja | Director | Open-market sale | 1,152 | $258.80 | $298.1K | Form 4 |
| 2026-08-31 | Foo Lisa Y | Officer (EVP, Chief Operating Officer) | Open-market sale | 24,000 | $266.32 | $6.39M | Form 4 |
| 2026-08-28 | HANEY CECIL D | Director | Bona fide gift | 150 | — | $0 | Form 4 |
| 2026-08-25 | Sutaria Saumya | Director, Officer (CEO) | Open-market sale | 7,899 | $275.26 | $2.17M | Form 4 |
| 2026-08-25 | Sutaria Saumya | Director, Officer (CEO) | Open-market sale | 24,881 | $274.10 | $6.82M | Form 4 |
| 2026-08-25 | Sutaria Saumya | Director, Officer (CEO) | Open-market sale | 17,220 | $273.34 | $4.71M | Form 4 |
| 2026-08-24 | Sutaria Saumya | Director, Officer (CEO) | Open-market sale | 36,656 | $278.90 | $10.22M | Form 4 |
| 2026-08-24 | Sutaria Saumya | Director, Officer (CEO) | Open-market sale | 13,344 | $278.17 | $3.71M | Form 4 |
| 2026-08-24 | HANEY CECIL D | Director | Open-market sale | 1,300 | $278.03 | $361.4K | Form 4 |
| 2026-08-07 | Romo Tammy | Director | Open-market sale | 2,500 | $260.83 | $652.1K | Form 4 |
| 2026-08-06 | Romo Tammy | Director | Open-market sale | 4,922 | $264.15 | $1.30M | Form 4 |
| 2026-08-05 | Blunt Roy | Director | Open-market sale | 600 | $262.68 | $157.6K | Form 4 |
| 2026-07-29 | Foo Lisa Y | Officer (EVP, Chief Operating Officer) | Open-market sale | 10,000 | $258.03 | $2.58M | Form 4 |
| 2026-07-27 | BIERMAN JAMES L | Director | Open-market sale | 5,000 | $244.96 | $1.22M | Form 4 |
| 2026-07-27 | Arbour Paola M | Officer (EVP, Chief Information Officer) | Open-market sale | 10,878 | $243.90 | $2.65M | Form 4 |
| 2026-07-27 | Lynch Christopher S. | Director | Open-market sale | 3,837 | $243.44 | $934.1K | Form 4 |
| 2026-05-28 | KERREY J ROBERT | Director | Open-market sale | 361 | $177.52 | $64.1K | Form 4 |
| 2026-05-28 | KERREY J ROBERT | Director | Open-market sale | 905 | $176.89 | $160.1K | Form 4 |
| 2026-05-28 | KERREY J ROBERT | Director | Open-market sale | 713 | $175.13 | $124.9K | Form 4 |
| 2026-05-28 | KERREY J ROBERT | Director | Open-market sale | 1,690 | $173.97 | $294.0K | Form 4 |
| 2026-05-28 | KERREY J ROBERT | Director | Open-market sale | 1,969 | $173.12 | $340.9K | Form 4 |
| 2026-05-27 | Fitzgerald Meghan | Director | Grant / award / vesting (derivative) | 1,188 | — | $0 | Form 4 |
| 2026-05-27 | KERREY J ROBERT | Director | Grant / award / vesting (derivative) | 1,464 | — | $0 | Form 4 |
| 2026-05-27 | Lynch Christopher S. | Director | Grant / award / vesting (derivative) | 1,188 | — | $0 | Form 4 |
| 2026-05-27 | Romo Tammy | Director | Grant / award / vesting (derivative) | 1,188 | — | $0 | Form 4 |
| 2026-05-27 | BIERMAN JAMES L | Director | Grant / award / vesting (derivative) | 1,188 | — | $0 | Form 4 |
| 2026-05-27 | HANEY CECIL D | Director | Grant / award / vesting (derivative) | 1,188 | — | $0 | Form 4 |
| 2026-05-27 | FISHER RICHARD W | Director | Grant / award / vesting (derivative) | 1,188 | — | $0 | Form 4 |
| 2026-05-27 | West Nadja | Director | Grant / award / vesting (derivative) | 1,188 | — | $0 | Form 4 |
| 2026-05-27 | West Nadja | Director | Open-market sale | 3,000 | $177.35 | $532.0K | Form 4 |
| 2026-05-27 | MARK RICHARD J | Director | Grant / award / vesting (derivative) | 1,188 | — | $0 | Form 4 |
| 2026-05-27 | Blunt Roy | Director | Grant / award / vesting (derivative) | 1,188 | — | $0 | Form 4 |
| 2026-05-27 | Agarwala Vineeta | Director | Grant / award / vesting (derivative) | 1,188 | — | $0 | Form 4 |
| 2026-05-22 | Blunt Roy | Director | Option exercise / conversion (derivative) | 1,333 | — | — | Form 4 |
| 2026-05-22 | Blunt Roy | Director | Disposition to the issuer | 493 | $173.78 | $85.7K | Form 4 |
| 2026-05-22 | Blunt Roy | Director | Option exercise / conversion | 1,333 | — | — | Form 4 |
| 2026-05-22 | KERREY J ROBERT | Director | Option exercise / conversion (derivative) | 1,643 | — | — | Form 4 |
| 2026-05-22 | KERREY J ROBERT | Director | Disposition to the issuer | 607 | $173.78 | $105.5K | Form 4 |
| 2026-05-22 | KERREY J ROBERT | Director | Option exercise / conversion | 1,643 | — | — | Form 4 |
| 2026-05-22 | MARK RICHARD J | Director | Option exercise / conversion (derivative) | 1,333 | — | — | Form 4 |
| 2026-05-22 | MARK RICHARD J | Director | Disposition to the issuer | 493 | $173.78 | $85.7K | Form 4 |
| 2026-05-22 | MARK RICHARD J | Director | Option exercise / conversion | 1,333 | — | — | Form 4 |
| 2026-05-22 | HANEY CECIL D | Director | Option exercise / conversion (derivative) | 1,333 | — | — | Form 4 |
| 2026-05-22 | HANEY CECIL D | Director | Disposition to the issuer | 493 | $173.78 | $85.7K | Form 4 |
| 2026-05-22 | HANEY CECIL D | Director | Option exercise / conversion | 1,333 | — | — | Form 4 |
| 2026-05-22 | Agarwala Vineeta | Director | Option exercise / conversion (derivative) | 1,333 | — | — | Form 4 |
| 2026-05-22 | Agarwala Vineeta | Director | Option exercise / conversion | 1,333 | — | — | Form 4 |
| 2026-05-22 | Fitzgerald Meghan | Director | Option exercise / conversion (derivative) | 1,333 | — | — | Form 4 |
| 2026-05-22 | Fitzgerald Meghan | Director | Disposition to the issuer | 493 | $173.78 | $85.7K | Form 4 |
| 2026-05-22 | Fitzgerald Meghan | Director | Option exercise / conversion | 1,333 | — | — | Form 4 |
| 2026-05-22 | FISHER RICHARD W | Director | Option exercise / conversion (derivative) | 1,333 | — | — | Form 4 |
| 2026-05-22 | FISHER RICHARD W | Director | Disposition to the issuer | 493 | $173.78 | $85.7K | Form 4 |
| 2026-05-22 | FISHER RICHARD W | Director | Option exercise / conversion | 1,333 | — | — | Form 4 |
| 2026-05-22 | Romo Tammy | Director | Option exercise / conversion (derivative) | 1,333 | — | — | Form 4 |
| 2026-05-22 | Romo Tammy | Director | Disposition to the issuer | 493 | $173.78 | $85.7K | Form 4 |
| 2026-05-22 | Romo Tammy | Director | Option exercise / conversion | 1,333 | — | — | Form 4 |
| 2026-05-22 | West Nadja | Director | Option exercise / conversion (derivative) | 1,333 | — | — | Form 4 |
| 2026-05-22 | West Nadja | Director | Disposition to the issuer | 493 | $173.78 | $85.7K | Form 4 |
| 2026-05-22 | West Nadja | Director | Option exercise / conversion | 1,333 | — | — | Form 4 |
| 2026-05-22 | Lynch Christopher S. | Director | Option exercise / conversion (derivative) | 1,333 | — | — | Form 4 |
| 2026-05-22 | Lynch Christopher S. | Director | Option exercise / conversion | 1,333 | — | — | Form 4 |
| 2026-05-22 | BIERMAN JAMES L | Director | Option exercise / conversion (derivative) | 1,333 | — | — | Form 4 |
| 2026-05-22 | BIERMAN JAMES L | Director | Option exercise / conversion | 1,333 | — | — | Form 4 |
Ask the chat about THC's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: Tenet Healthcare (THC).
Last updated 2026-09-14 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.